Figure 2
From: Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Probability of progression-free survival (a) and androgen deprivation therapy-free survival (b).
Figure 2 | Radiation Oncology
From: Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Probability of progression-free survival (a) and androgen deprivation therapy-free survival (b).